Rise in child infections strains Northern China's hospitals
Chinese doctors have reported a sharp increase in human metapneumovirus (hMPV) infections, as confirmed by the national medical authorities. According to the "Independent," the rise in infections primarily affects children under 14 years of age and is particularly noticeable in northern China.
Recordings on social media depict overwhelmed hospitals, reminiscent of the early days of the COVID-19 pandemic. However, Beijing reassures the public that the rise in infections is typical for winter. Symptoms of the infection include high fever, cough, and sore throat, and in some cases, it can lead to bronchitis or pneumonia.
Viruses such as metapneumovirus (hMPV) and concurrent influenza and RSV infections raise epidemiological concerns worldwide. Currently, there is no vaccine or specific medication for hMPV, which is causing numerous hospitalizations due to acute bronchitis.
Viruses like hMPV tend to mutate, making them difficult to control and predict regarding epidemic progression.
Experts warn that viral infections can lead to severe complications, especially during the fall and winter. The possibility of co-infection with influenza, RSV, and metapneumovirus presents additional challenges for healthcare, as it places a greater burden on the immune system and increases the risk of complications for patients.
Neighbouring countries react. WHO has made a decision
Neighbouring countries like Hong Kong and India are monitoring the situation. Hong Kong has reported several cases of hMPV, while India has not observed an increase in respiratory illnesses. In Iran, medical authorities reassured that there was no cause for concern, and the WHO did not consider the situation to require special action.
The most affected are children and the elderly, who, due to weakened immune systems, are more susceptible to severe illness progression. The rise in hospitalizations due to respiratory illnesses requires healthcare systems to be prepared to meet patient needs and to implement new epidemic management strategies.
